Shani Alexander

Apollo brings better sleep and stress relief with Smartvibes

Nov. 27, 2023

Apollo Neuroscience Inc. recently introduced a new software called Smartvibes for its Apollo wearable device to help people lower their stress levels and sleep better. There are a growing number of wearable technologies that have sensors that continuously measure physiological signals to help individuals monitor and manage their health conditions.

Vicentra launches hybrid closed-loop diabetes system

Nov. 22, 2023

By Shani Alexander

With hybrid closed-loop systems for automated insulin delivery increasingly being seen as life changing for people with diabetes, Vicentra BV has teamed up with Diabeloop SA and Dexcom Inc. to launch a system to help people with type 1 diabetes manage their condition.

Astrazenca launches Evinova digital health business

Nov. 21, 2023

By Shani Alexander

Astrazeneca plc launched a health-tech business aimed at bringing to market digital technological solutions that will optimize clinical trial design and delivery. The company, called Evinova, will offer solutions to reduce the time and cost of developing new drugs, bring care closer to patients at home and reduce the burden on health systems.

Surmodics reveals positive data for its Sundance Sirolimus DCB

Nov. 20, 2023

By Shani Alexander

Surmodics Inc. reported positive two-year data from the SWING trial, the first-in-human study to look at the safety of its Sundance Sirolimus drug-coated balloon (DCB) when used to treat occlusive disease of the infrapopliteal arteries. Results presented at the VEITHsymposium in New York showed that the Sundance Sirolimus DCB demonstrated an excellent safety profile and achieved primary patency of 71.4% at 24 months in the per protocol analysis population.

VEITHsymposium

Xeltis’ vascular Axess graft implant sees no infection after one year

Nov. 17, 2023

By Shani Alexander

One-year data from Xeltis AG’s first-in-human Axess vascular conduit trial showed outstanding results in patients with end stage renal disease who were deemed unsuitable for arteriovenous (AV) fistula creation. The results, presented at the VEITHsymposium in New York, showed 100% secondary patency, 78% primary assisted patency and no infections were observed in data from 20 patients implanted with the Axess conduit.

Gilde Healthcare closes fund at €740M

Nov. 16, 2023

By Shani Alexander

Gilde Healthcare Partners BV finally closed its Venture & Growth VI fund after raising €740 million (US$803 million) in commitments. The venture capital firm added €140 million to the €600 million unveiled earlier in the year due to strong interest from institutional investors.

Jefferies London Healthcare Conference

Jeffries says health care M&A activity expected to rise next year

Nov. 15, 2023

By Shani Alexander

Senior leaders and investors in the health care sector expect mergers and acquisitions (M&A) activity to continue to pick up next year but this will be corporate led rather than private equity, according to a report by global investment bank Jefferies.

Intuitive Surgical’s Ion endoluminal system and Siemens Healthiness’ Cios Spin

Jefferies 2023 London Healthcare Conference

Siemens focused on transforming Diagnostic business CFO says

Nov. 15, 2023

By Shani Alexander

Siemens Healthineers AG appears to be committed to its Diagnostics business after Jochen Schmitz, CFO, pushed back at rumors speculating that the German company was looking at options for the underperforming segment, including a sale.

Dollar sign and Euro symbol in cogwheels

Jefferies London Healthcare Conference

Jeffries says health care M&A activity expected to rise next year

Nov. 14, 2023

By Shani Alexander

Senior leaders and investors in the health care sector expect mergers and acquisitions (M&A) activity to continue to pick up next year but this will be corporate led rather than private equity, according to a report by global investment bank Jefferies. At the same time, many executives remained concerned about the lack of funding in the sector as it was identified as the number one threat.

Researchers find that 3D-printed tissues could help repair brain injuries

Nov. 14, 2023

By Shani Alexander

Researchers have for the first time used human neural stem cells to print 3D brain tissues that mimic the architecture of the brain’s outer layer, the cerebral cortex. This breakthrough technique, developed by a team from the U.K.’s University of Oxford, could one day be used to provide tailored repairs to the millions of people who suffer from severe brain injuries, for which there is no effective treatment.